These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18365402)

  • 1. Detection of soluble HLA-G and its correlation with kidney transplant outcome.
    Kaneku H
    Clin Transpl; 2006; ():447-54. PubMed ID: 18365402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
    Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
    Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble HLA class I molecules exert differentiated influence on renal graft condition.
    Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S
    Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
    Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
    Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis.
    Mach P; Blecharz P; Basta P; Marianowski P; Skret-Magierlo J; Kojs Z; Grabiec M; Wicherek L
    Am J Reprod Immunol; 2010 May; 63(5):387-95. PubMed ID: 20146732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA-G expression and renal graft acceptance.
    Qiu J; Terasaki PI; Miller J; Mizutani K; Cai J; Carosella ED
    Am J Transplant; 2006 Sep; 6(9):2152-6. PubMed ID: 16780545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
    Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
    Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and identification of soluble HLA-G isoforms.
    Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation.
    Luque J; Torres MI; Aumente MD; Lozano JM; García-Jurado G; González R; Alvarez-López MR; Arizón JM; Peña J
    Transpl Immunol; 2006 Dec; 17(1):70-3. PubMed ID: 17157221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and MICA antibodies: further evidence of their impact on graft loss two years after their detection.
    Morales-Buenrostro LE; Rodríguez-Romo R; de Leo C; López M; Pérez-Garrido J; Uribe-Uribe N; Alberú J
    Clin Transpl; 2006; ():207-18. PubMed ID: 18365379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance.
    Bahri R; Naji A; Menier C; Charpentier B; Carosella ED; Rouas-Freiss N; Durrbach A
    J Immunol; 2009 Dec; 183(11):7054-62. PubMed ID: 19915057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
    Ozawa M; Terasaki PI; Lee JH; Castro R; Alberu J; Alonso C; Alvarez I; Toledo R; Alvez H; Monterio M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Conca R; Gomez B; Monteon F; Grosse-Wilde H; Heinemann F; Humar I; Kamoun M; Kimball P; Kobayashi T; Kupatawintu P; Leech S; LeFor W; Mehra N; Panigrahi A; Naumova E; Norman D; Piazza A; Poli F; Colombo B; Roy R; Schonemann C; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
    Tissue Antigens; 2007 Apr; 69 Suppl 1():174-9. PubMed ID: 17445195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HLA antibodies: detection and effect on renal transplant function.
    Koka P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):243-4. PubMed ID: 8438286
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.